About Roche
F. Hoffmann-La Roche AG is a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Roche is the world's largest biotech company and a global leader in cancer care.
Our History
Founded in 1896 by Fritz Hoffmann-La Roche in Basel, Switzerland, the company has a 125+ year legacy of groundbreaking medical innovations. Roche introduced the first synthetic tranquilizers and later became a pioneer in biotechnology.
Pharmaceuticals Division
Roche is a global leader in oncology with blockbuster drugs like Herceptin, Avastin, Rituxan, and more recently Tecentriq and Polivy. The company also excels in immunology, neuroscience, and hemophilia treatments.
Diagnostics Division
Roche Diagnostics is the world leader in in-vitro diagnostics, offering products for diabetes management, molecular diagnostics, tissue diagnostics, and point-of-care testing. The division generated significant revenue during the COVID-19 pandemic.
Global Impact
Headquartered in Basel, Roche employs over 100,000 people across more than 100 countries. The company reported $64.4 billion in revenue in 2023, with the diagnostics division contributing significantly to overall growth.
Leadership
Thomas Schinecker became CEO in 2023, succeeding Severin Schwan. The company remains under the majority ownership of the Hoffmann and Oeri families through pooled shares.